Horsch L, Baron J, Sung PJ, Wang ES, et al. Management and risk mitigation strategies for FLT3-ITD+ acute myeloid leukemia: clinical utilization of quizartinib. Leuk Lymphoma 2026 May 30:1-8. doi: 10.1080/10428194.2026.2676107.
PMID: 42217224